FIELD: pharmacology.
SUBSTANCE: invention relates to a pharmaceutical composition for fluorescent diagnosis of pathological changes in skin and mucous membranes comprising ytterbium complex dipotassium salt of 2,4-dimethoxyhematoporphyrin IX in an amount of 0.05÷0.1 wt %, N-methylglucosamine and glycerin, and a mixture of Cremophor with DMSO at a ratio of 1:18÷20, or Tizol, or a Cremophor and Tizol mixture at a ratio of 1: 8÷10, or Kalgel as a Cremophor-containing gel base.
EFFECT: simplified process of diagnosis at diseased skin and mucous membranes; facilitated treatment monitoring; ability to identify pathological processes occurrence in the places of their localization, which can not be determined visually; significant reduction in the optimal time of pharmaceutical composition accumulation in various tumors to less than 1 hour.
3 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NANOCOMPOSITES FOR MAGNETOLUMINESCENT THERANOSTICS OF NEOPLASMS | 2021 |
|
RU2766513C1 |
| YTTERBIUM COMPLEX OF 2,4-DIMETHOXYHEMATOPORPHYRIN IX DIPOTASSIUM SALT AS FLUORESCENT TAG FOR EARLY CANCER DIAGNOSIS | 2009 |
|
RU2411243C1 |
| NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 |
|
RU2578976C2 |
| METHOD OF PRODUCING A DIPOTASSIUM SALT OF THE 2,4-DI(α-METHOXYETHYL)DEUTEROPORPHYRIN IX ACETYLACETONATE YTTERBIUM COMPLEX | 2019 |
|
RU2697418C1 |
| YTTERBIUM TETRAPYRAZOLYL PORPHYRIN COMPLEXES AS FLUORESCENT TAGS TO DIAGNOSE MALIGNANT GROWTHS | 2008 |
|
RU2372099C1 |
| COMPOSITE NANOPARTICLES FOR PHOTODYNAMIC DIAGNOSIS | 2011 |
|
RU2463074C1 |
| DEVICE FOR LUMINISCENT DIAGNOSTICS OF NEOPLASMS | 2012 |
|
RU2483678C1 |
| METHOD FOR INVESTIGATING TISSUE MALIGNANCY PROCESS IN EXPERIMENTAL ANIMALS | 1988 |
|
SU1621720A1 |
| THERAPY OF BACKGROUND, PRECANCEROUS, MALIGNANT AND METASTATIC DISEASES | 2009 |
|
RU2398607C1 |
| 5-AMINOLEVULINIC ACID ESTERS AS PHOTOSENSIBILIZING AGENTS IN PHOTOCHEMOTHERAPY | 1996 |
|
RU2191010C2 |
